Skip to main content

Animations

MJFF Publications

1671 - 1680 of 9033 Results
Title
Year
  • Year
  • 2014
  • 2014
  • 2014
  • 2014
  • 2012
  • 2014
  • 2015
  • 2016
  • 2015
  • 2014
  • Summary Details
    OPEN
    Title: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528
    Citation Count: 239
  • Summary Details
    OPEN
    Title: Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2704
    Citation Count: 402
  • Summary Details
    OPEN
    Title: Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adult Life Span
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.445
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.313
    Citation Count: 219
  • Summary Details
    OPEN
    Title: Randomized Clinical Trial of 3 Types of Physical Exercise for Patients With Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.646
    Citation Count: 410
  • Summary Details
    OPEN
    Title: Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1973
    Citation Count: 99
  • Summary Details
    RESTRICTED
    Title: Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.3098
    Citation Count: 203
  • Summary Details
    OPEN
    Title: Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.4800
    Citation Count: 177
  • Summary Details
    OPEN
    Title: Whole-Exome Sequencing in Familial Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.3266
    Citation Count: 76
  • Summary Details
    OPEN
    Title: APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1455
    Citation Count: 210
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.